Skip to contentB
Biogen Inc.
B
BIIBBiogen Inc. Q4 2017 · 10-K
Revenue$3.31B$3.31B+15.1% vs Q4 2016 Net Income-$297.40M-$297.40MN/M vs Q4 2016 EPS Diluted-$1.40-$1.40N/M vs Q4 2016 Gross Profit$2,797,800,000+12.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biogen Inc. · CIK 875045 · Engraved from SEC EDGAR
derived
Operating Cash Flowderived$1,518,300,000−4.0% Free Cash Flowderived$1,287,700,000−8.0% Margins · derivedGross margin84.6%−2.2 pt vs Q4 2016
Operating margin44.3%+13.4 pt vs Q4 2016
Net margin-9.0%−31.6 pt vs Q4 2016
ended Dec 31, 2017 · filed Feb 1, 2018 · 32 d after period end